Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine
Clinical trial NCT04960397 · TERMINATED
Trial details
- NCT number
- NCT04960397
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2024-04-12
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.